|
|
|
|
Vol. 303, Issue 2, 520-526, November 2002
Department of Pharmacology, University of Bonn, Bonn, Germany
In the search for P2-receptors modulating the stimulation-evoked
entry of calcium at processes of PC12 cells differentiated in the
presence of nerve growth factor and neurotrophin-3, electrically evoked
increases in free calcium were assessed by fura-2 microfluorimetry. Omission of calcium and addition of cadmium (100 µM) or the N-type calcium channel blocker
-conotoxin GVIA (0.5 µM) abolished or markedly reduced the evoked responses. The P2Y-receptor agonists 2-methylthio adenosine 5'-diphosphate (2-methylthio-ADP), ADP, and
adenosine 5'-O-(2-thiodiphosphate) (ADP
S) inhibited
the electrically evoked entry of calcium without any changes in basal
calcium concentrations. 2-Methylthio-ADP was the most potent agonist.
Adenosine,
P1,P4-di(adenosine-5')-tetraphosphate (Ap4A),
UDP, and UTP (30 µM each) had no effect. The effect of ADP
S (30 µM) was abolished by the P2-antagonists reactive blue 2 (3 µM),
suramin (100 µM), 2-methylthio-AMP (10 µM),
p-chloromercuriphenyl sulfonic acid (1 µM), and AR-C 69931MX
[N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-
,
-dichloromethylene adenosine 5'-triphosphate] (300 nM). In contrast,
pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (10 µM),
the selective P2Y1-receptor antagonist MRS 2179 (N6-methyl-2'-deoxyadenosine
3',5'-bisphosphate; 10 µM), as well as the adenosine
A1-receptor antagonist DPCPX
(8-cyclopentyl-1,3-dipropylxanthine; 100 nM), caused no change.
Pretreatment with pertussis toxin abolished the effect of ADP
S.
Reverse transcriptase-polymerase chain reaction revealed the presence
of mRNA for P2Y12-receptors in nondifferentiated and differentiated
PC12 cells. The results indicate that processes of differentiated PC12
cells possess P2Y12-receptors coupling to pertussis toxin-sensitive
G-proteins and mediating an inhibition of the stimulation-evoked entry
of calcium through
-conotoxin GVIA-sensitive calcium channels. This
suggests a role of P2Y12-receptors in neuromodulation in addition to
their involvement in platelet aggregation.
This article has been cited by other articles:
![]() |
K. Hoffmann, Y. Baqi, M. S. Morena, M. Glanzel, C. E. Muller, and I. von Kugelgen Interaction of New, Very Potent Non-Nucleotide Antagonists with Arg256 of the Human Platelet P2Y12 Receptor J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 648 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Morrell, H. Sun, M. Ikeda, J.-C. Beique, A. M. Swaim, E. Mason, T. V. Martin, L. E. Thompson, O. Gozen, D. Ampagoomian, et al. Glutamate mediates platelet activation through the AMPA receptor J. Exp. Med., March 17, 2008; 205(3): 575 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ennion, A. D. Powell, and E. P. Seward Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells Mol. Pharmacol., September 1, 2004; 66(3): 601 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gerevich, S. J. Borvendeg, W. Schroder, H. Franke, K. Wirkner, W. Norenberg, S. Furst, C. Gillen, and P. Illes Inhibition of N-Type Voltage-Activated Calcium Channels in Rat Dorsal Root Ganglion Neurons by P2Y Receptors Is a Possible Mechanism of ADP-Induced Analgesia J. Neurosci., January 28, 2004; 24(4): 797 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Queiroz, C. Talaia, and J. Goncalves ATP Modulates Noradrenaline Release by Activation of Inhibitory P2Y Receptors and Facilitatory P2X Receptors in the Rat Vas Deferens J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 809 - 815. [Abstract] [Full Text] [PDF] |
||||